Credit Suisse Ag Repligen Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Repligen Corp stock. As of the latest transaction made, Credit Suisse Ag holds 85,380 shares of RGEN stock, worth $14.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

85,380

Previous 95,349 10.46%

Holding current value

$14.2 Million

Previous $17.1 Million 8.4%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$170.78 - $208.42 $1.7 Million - $2.08 Million	-9,969 Reduced 10.46%	85,380 $15.7 Million
Q4 2023 Feb 08, 2024	BUY	$114.17 - $185.35 $498,694 - $809,608	4,368 Added 4.8%	95,349 $17.1 Million
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $107,970 - $137,324	-778 Reduced 0.85%	90,981 $14.5 Million
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $6.87 Million - $8.95 Million	49,635 Added 117.83%	91,759 $13 Million
Q1 2023 May 10, 2023	SELL	$154.26 - $198.1 $21,442 - $27,535	-139 Reduced 0.33%	42,124 $7.09 Million
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $1.68 Million - $2.27 Million	-10,314 Reduced 19.62%	42,263 $7.16 Million
Q3 2022 Nov 10, 2022	BUY	$160.42 - $256.21 $121,598 - $194,207	758 Added 1.46%	52,577 $9.84 Million
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $192,168 - $256,835	-1,366 Reduced 2.57%	51,819 $8.42 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $473,415 - $757,628	2,937 Added 5.85%	53,185 $10 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $2.67 Million - $3.28 Million	-10,786 Reduced 17.67%	50,248 $13.3 Million
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $800,309 - $1.33 Million	4,109 Added 7.22%	61,034 $17.6 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $145,799 - $194,215	879 Added 1.57%	56,925 $11.4 Million
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $316,549 - $397,086	1,755 Added 3.23%	56,046 $10.9 Million
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $2.41 Million - $3.36 Million	-16,262 Reduced 23.05%	54,291 $10.4 Million
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $507,313 - $655,396	4,141 Added 6.24%	70,553 $10.4 Million
Q2 2020 Aug 12, 2020	BUY	$94.33 - $140.48 $2.48 Million - $3.69 Million	26,279 Added 65.48%	66,412 $8.21 Million
Q1 2020 May 13, 2020	SELL	$84.96 - $109.14 $111,977 - $143,846	-1,318 Reduced 3.18%	40,133 $3.88 Million
Q4 2019 Feb 12, 2020	SELL	$73.84 - $93.08 $1.93 Million - $2.43 Million	-26,152 Reduced 38.68%	41,451 $3.84 Million
Q3 2019 Nov 12, 2019	BUY	$76.65 - $95.51 $3.34 Million - $4.16 Million	43,574 Added 181.34%	67,603 $5.18 Million
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $3.57 Million - $5.66 Million	-65,874 Reduced 73.27%	24,029 $2.07 Million
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $1.1 Million - $1.4 Million	22,296 Added 32.98%	89,903 $5.31 Million
Q4 2018 Feb 13, 2019	BUY	$48.26 - $68.88 $1.87 Million - $2.67 Million	38,819 Added 134.84%	67,607 $3.57 Million
Q3 2018 Nov 13, 2018	SELL	$46.8 - $58.97 $309,394 - $389,850	-6,611 Reduced 18.68%	28,788 $1.6 Million
Q2 2018 Aug 14, 2018	SELL	$35.26 - $47.04 $184,903 - $246,677	-5,244 Reduced 12.9%	35,399 $1.67 Million
Q1 2018 May 15, 2018	BUY	$30.92 - $37.27 $215,388 - $259,622	6,966 Added 20.68%	40,643 $1.47 Million
Q4 2017 Feb 14, 2018	SELL	$32.53 - $38.92 $1.99 Million - $2.38 Million	-61,145 Reduced 64.48%	33,677 $1.22 Million
Q3 2017 Nov 14, 2017	SELL	$36.98 - $46.06 $747,254 - $930,734	-20,207 Reduced 17.57%	94,822 $3.64 Million
Q2 2017 Aug 14, 2017	BUY	N/A	115,029	115,029 $4.77 Million

Others Institutions Holding RGEN

# of Institutions

485

Shares Held

54.1M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account